DENQUIVLA Trademark

Trademark Overview


On Tuesday, March 7, 2023, a trademark application was filed for DENQUIVLA with the United States Patent and Trademark Office. The USPTO has given the DENQUIVLA trademark a serial number of 97826060. The federal status of this trademark filing is REGISTERED as of Tuesday, December 19, 2023. This trademark is owned by Fresenius Kabi Deutschland GmbH. The DENQUIVLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone
denquivla

General Information


Serial Number97826060
Word MarkDENQUIVLA
Filing DateTuesday, March 7, 2023
Status700 - REGISTERED
Status DateTuesday, December 19, 2023
Registration Number7249312
Registration DateTuesday, December 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFresenius Kabi Deutschland GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Party NameFresenius Kabi Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Party NameFresenius Kabi Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 19, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 21, 2023ASSIGNED TO EXAMINER
Friday, July 28, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, July 28, 2023ASSIGNED TO LIE
Tuesday, March 21, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, March 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 10, 2023NEW APPLICATION ENTERED